Immunization with a Polyprotein Vaccine Consisting of the T-Cell Antigens Thiol-Specific Antioxidant, Leishmania major Stress-Inducible Protein 1, and Leishmania Elongation Initiation Factor Protects against Leishmaniasis

Development of an effective vaccine against Leishmania infection is a priority of tropical disease research. We have recently demonstrated protection against Leishmania major in the murine and nonhuman primate models with individual or combinations of purified leishmanial recombinant antigens delive...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Coler, Rhea N., Skeiky, Yasir A. W., Bernards, Karen, Greeson, Kay, Carter, Darrick, Cornellison, Charisa D., Modabber, Farrokh, Campos-Neto, Antonio, Reed, Steven G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2002
Ämnen:
Microbial Immunity and Vaccines
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC128156/
https://ncbi.nlm.nih.gov/pubmed/12117930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.70.8.4215-4225.2002
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk